Compare AM & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AM | LNTH |
|---|---|---|
| Founded | 2013 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 5.6B |
| IPO Year | 2017 | 2014 |
| Metric | AM | LNTH |
|---|---|---|
| Price | $21.00 | $93.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $22.50 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 2.5M | 751.2K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ 3.61 | N/A |
| EPS | 0.25 | ★ 1.80 |
| Revenue | ★ $1,188,426,000.00 | $343,374,000.00 |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $7.05 | $14.19 |
| P/E Ratio | $83.96 | ★ $51.71 |
| Revenue Growth | ★ 7.43 | 3.62 |
| 52 Week Low | $16.77 | $47.27 |
| 52 Week High | $23.84 | $94.86 |
| Indicator | AM | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 73.14 |
| Support Level | $20.40 | $72.35 |
| Resistance Level | $22.25 | N/A |
| Average True Range (ATR) | 0.49 | 2.84 |
| MACD | -0.02 | 0.67 |
| Stochastic Oscillator | 31.89 | 89.22 |
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.